Who are the major dialysis tenants?

DaVita Inc. and Fresenius Medical Care control approximately 80 percent of the U.S. dialysis market between them. Together they are the dominant tenants in dialysis center NNN real estate.

Are dialysis centers considered medical office or net lease?

Both. Dialysis centers operate as freestanding net-leased credit-tenant retail with healthcare characteristics. Most institutional investors classify dialysis as STNL credit retail rather than medical office.

What is the typical lease term?

15 to 25 year initial term is typical, with multiple 5-year renewal options. The long initial term reflects tenant build-out investment in the specialized facility.

What credit ratings do DaVita and Fresenius carry?

DaVita is rated BB+ by S&P (high yield, just below investment grade). Fresenius Medical Care is rated Baa3 by Moody's (investment grade).

Are dialysis centers financeable through 1031 exchange?

Yes. Dialysis centers are commonly acquired by 1031 exchange buyers seeking credit-tenant net-leased income. The asset class fits well within the 45-day identification and 180-day closing windows.

What is the typical cap rate?

Stabilized DaVita and Fresenius dialysis NNN typically trades at 6.50 to 7.50 percent cap rates depending on lease term remaining, location, and market dynamics.

How does Medicare reimbursement affect dialysis financing?

Medicare is a primary payor for dialysis services (covers 80 percent of dialysis patients). Medicare reimbursement changes affect tenant operating economics and lender appetite.

Can dialysis centers be financed at high leverage?

Yes. Strong tenant credit and long initial lease terms support 65 to 75 percent LTV through specialty STNL lenders, with conservative 55 to 65 percent through life co.

Dialysis Center Financing

At a Glance

Dialysis Center Financing Snapshot

Typical loan size

$2M to $15M

Maximum LTV

65 to 75 percent

Typical DSCR floor

1.25x to 1.35x

Term

10 to 25 years (matched to lease)

Recourse

Non-recourse with carve-outs

Tenant credit

DaVita BB+ / Fresenius Baa3

Lease term

15 to 25 years initial

Lender count actively quoting

Approximately 30 to 50 STNL specialty

Capital Source Map

Where Dialysis Center Loans Come From

Dialysis center financing flows through CMBS conduits, life cos, specialty STNL lenders, 1031 exchange buyer pools, and conventional banks comfortable with credit-tenant net-leased real estate. The strong tenant credit (DaVita and Fresenius) supports tight pricing and broad lender appetite.

Capital Source	LTV / Down	Best Fit
Life insurance company	55 to 65 percent	Trophy long-WALT credit-tenant dialysis
CMBS conduit	65 to 70 percent	Stabilized credit-tenant dialysis $5M+
Specialty STNL lender	65 to 75 percent	Standard credit-tenant net-leased dialysis
Conventional bank balance sheet	60 to 70 percent	1031 exchange buyer with depository
1031 exchange buyer pool	100 percent	1031 exchange acquisition with subsequent financing

Pricing is indicative and reflects active CLS CRE quote pipeline as of April 2026. Actual pricing depends on property condition, sponsor profile, deal size, and market dynamics.

Deal Profile

Typical Dialysis Center Deal

Dialysis center transactions typically range from $2M for smaller suburban facilities to $15M for larger metro facilities. Per-square-foot pricing typically runs $400 to $700 reflecting credit-tenant net-leased characteristics. The asset class is concentrated in single-tenant build-to-suit facilities leased to DaVita or Fresenius.

Sponsor profiles include 1031 exchange buyers seeking credit-tenant net-leased real estate, institutional STNL investors, and specialty healthcare REITs. Owner-operator dialysis is uncommon at the institutional level given the DaVita and Fresenius market dominance.

Operating revenue is the triple-net rent paid by the tenant. Dialysis center NNN leases typically include CPI escalations or fixed annual escalations of 1 to 2.5 percent. The tenant pays all property expenses (taxes, insurance, maintenance, utilities).

What Lenders Look For

Dialysis Center Underwriting Considerations

Dialysis center underwriting evaluates the property, the tenant lease, the credit profile, and the location.

Tenant credit: DaVita BB+ (S&P) or Fresenius Baa3 (Moody's)
Lease term: 15 to 25 year initial term typical, with multiple 5-year renewal options
Lease structure: triple-net with CPI or fixed escalations
Location: medical office park or freestanding building, parking access, demographic alignment
Property condition: dialysis-specific build-out (water purification, treatment chairs, mechanical, plumbing)
WALT: weighted average lease term affects pricing
Renewal probability: tenant has invested significantly in the build-out, supporting renewal
Geographic concentration: portfolio concentration limits

Pitfalls We See

Common Dialysis Center Financing Pitfalls

Dialysis center transactions have specific failure modes around tenant credit changes, regulatory environment, and renewal timing.

Tenant credit downgrade: DaVita or Fresenius credit changes affect cap rates
Regulatory environment: Medicare reimbursement changes affect tenant operations
Lease expiration risk: lease expirations within 5 years compress cap rates
Specialized build-out: dialysis-specific facilities have limited adaptive reuse
Insurance: standard NNN insurance applies
Concentration risk: 80 percent of market in two tenants creates concentration risk
Adaptive reuse limited: dialysis facilities have limited reuse value to non-dialysis tenants
Build-to-suit dynamics: most dialysis centers are tenant-driven build-to-suit

From the CLS CRE Pipeline

A Real Dialysis Center Deal

On a $5.4M acquisition of a 6,400 square foot freestanding dialysis center in a Sun Belt suburban market, leased to DaVita on a 15-year triple-net lease with 1.5 percent annual escalations and 12 years of remaining initial term, the buyer was a 1031 exchange investor. Specialty STNL lender at 7.85 percent fixed 10-year, 65 percent LTV ($3.5M loan), with full defeasance. The buyer redeployed proceeds from a sold multifamily property under 1031 within the 180-day window. Year-one cash-on-cash return tracked underwritten 7 percent.

All deal references anonymize borrower and lender identities and use city-level geography only.

Dialysis center NNN is one of the cleanest credit-tenant net-leased plays in healthcare CRE. The DaVita and Fresenius credit profiles, long initial lease terms, and triple-net structures support consistent investor demand and competitive financing.
Trevor Damyan, Commercial Lending Solutions